Experience of the United Arab Emirates in the Use of Monoclonal Antibody Drug Sotrovimab in High-Risk Vaccinated and Unvaccinated Patients with COVID-19: An Observational Cohort Study

January 10, 2023

BMJ Open

This article describes the experience of using sotrovimab in patients with COVID-19 at high risk for disease progression and hospitalization within the United Arab Emirates (UAE).

Journal Article

Archived File

Access from source

Medical Research

Experience of the United Arab Emirates in the Use of Monoclonal Antibody Drug Sotrovimab in High-Risk Vaccinated and Unvaccinated Patients with COVID-19: An Observational Cohort Study

Recent Posts

Archives

Categories